Medtronic (MDT) Tariff Impact Reduces Estimates to $250 Million
Published on · Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowMedtronic plc (MDT) CEO Geoffrey Martha announced on June 8 that the company expects a tariff impact of $250 million for fiscal 2027, down from a previous estimate of $300 million. This figure includes $75 million expected in the first quarter. The reduction is due to supply chain adjustments, although Martha indicated that future tariff threats could alter these forecasts. Medtronic allocates $5 billion to $6 billion annually for innovation and reported a 78% revenue increase in cardiac ablation amidst ongoing cost pressures.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Medtronic plc (MDT)
Medtronic is one of the world’s largest medical-device makers.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier MDT news
- Medtronic (MDT) Reports Strong Q4 with $36 Billion Revenue Growth
- Medtronic (MDT) Gains FDA Approval for New Robotic Surgery Platform
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
